---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-010579"
form_type: "8-K"
ticker: "FSK"
cik: "0001422183"
company_name: "FS KKR Capital Corp"
filed_at: "2025-02-07T23:59:59+00:00"
generated_at: "2026-05-27T00:53:05.956474+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# FS KKR Capital Corp. Co-President Brian Gerson takes leave of absence effective Feb 3, 2025

## Summary
- Brian Gerson, Co-President, is on leave effective February 3, 2025.
- Daniel Pietrzak (Co-President, CIO, board member) and other officers assume Gerson's responsibilities.
- No reason for leave disclosed; no replacement named.
- Company's co-president structure remains with Pietrzak continuing in his roles.

## SEC filing metadata
- accession: 0001104659-25-010579
- form_type: 8-K
- ticker: FSK
- cik: 0001422183
- company_name: FS KKR Capital Corp
- filed_at: 2025-02-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1422183/000110465925010579/0001104659-25-010579-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1422183/000110465925010579/tm255888d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-010579
- JSON: https://secwatch.observer/filing/0001104659-25-010579.json
- Plain text: https://secwatch.observer/filing/0001104659-25-010579.txt

## Key facts
- Executive change
  Brian Gerson departed as Co-President at FS KKR Capital Corp.
  - Action: leave of absence
  - Role: Co-President
  source text: Brian Gerson, Co-President of FS KKR Capital Corp. (the “Company”), is on a leave of absence from the Company, effective February 3, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1422183/000110465925010579/0001104659-25-010579-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.